nirogacestat
springworks therapeutics
['nirogacestat', 'defi ']
in the phase 3 defi trial, nirogacestat showed sustained reduction of pain for patients with progressing desmoid tumors vs placebo. #asco2023 
Oncology news and insights from leading researchers and cancer centers.